Final Results of RTOG 9601 published - practice changing
Published yesterday in NEJM (http://www.nejm.org/doi/full/10.1056/NEJMoa1607529)
They took men with PSA failure after prostatectomy and performed a placebo-controlled, double-blind trial of prostate bed XRT with or without 24 months of biclutamide.
12 year OS = 76% with biclutamide, 71% without
Similar statistically significant results were seen when looking at prostate cancer specific survival and development of metastatic disease.
The main side effect was gynecomastia.
I...
Final Results of RTOG 9601 published - practice changing
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Gfunk6 Source Type: forums
More News: Cancer | Cancer & Oncology | Gynecomastia | Prostate Cancer | Statistics | Students | Universities & Medical Training